Join
Live feed
·
INSIDERFilingvia Quantisnow
Revelation Biosciences Inc. logo

Chief Financial Officer Zygmont Chester Stanley Iii was granted 78,145 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
REVB· Revelation Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REVB (Revelation Biosciences Inc.) and more on Quantisnow.